• OPEN AN ACCOUNT
Indian Indices
Nifty
24,008.00 -265.80
(-1.10%)
Sensex
79,454.47 -880.34
( -1.10%)
Bank Nifty
53,595.25 -770.40
( -1.42%)
Nifty IT
35,880.10 -122.35
( -0.34%)
Global Indices
Nasdaq
41,380.81 245.84
(0.60%)
Dow Jones
5,684.33 32.05
(0.57%)
Hang Seng
37,492.25 563.62
(1.53%)
Nikkei 225
8,531.61 -27.72
(-0.32%)
Forex
USD-INR
84.70 0.29
(0.35%)
EUR-INR
96.08 0.41
(0.42%)
GBP-INR
112.96 0.38
(0.34%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
139.278683
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
65.18
1095.29
EPS(TTM)
Face Value()
Div & Yield %
28.52
10
0
 

srs ltd
Andhra Cements reports standalone net loss of Rs 43.73 crore in the December 2024 quarter
Jan 24,2025
Net Loss of Andhra Cements reported to Rs 43.73 crore in the quarter ended December 2024 as against net loss of Rs 21.19 crore during the previous quarter ended December 2023. Sales declined 32.26% to Rs 66.33 crore in the quarter ended December 2024 as against Rs 97.92 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales66.3397.92 -32
OPM %-12.534.68 -
PBDT-25.37-14.98 -69
PBT-43.73-30.57 -43
NP-43.73-21.19 -106